Search for: "EISAI, Co., Ltd" Results 1 - 20 of 46
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jan 2020, 4:40 am by Tom Kosakowski
(OIST Posting; OIST Policy 42.)Note: A couple years ago, Bruce McLin, the former HR manager with OIST worked with Noriko Tada (Ombuds with Guidea for Eisai Co., Ltd.), Nick Diehl (then Ombuds for the Asian Development Bank) and Charmhee Kim (Ombuds with McKinsey & Co.) on presentations in Japan and an article for the Japan Institute for Labour Policy and Training Report.Related posts: Ombuds to Speak at Hitotsubashi University; Japan Institute for… [read post]
4 Apr 2017, 1:10 pm by Tom Kosakowski
 In November 2016, Noriko Tada, the Ombudsperson with Guidea for Eisai Co., Ltd., arranged a series of informational events in Tokyo about Ombuds. [read post]
5 May 2013, 9:44 pm by Patent Docs
Eisai R&D Management Co., Ltd. v. [read post]
3 Mar 2013, 12:06 pm by Rajiv Kr. Choudhry
Rajanbabu 1424/CHENP/2008 EISAI R&D MANAGEMENT CO, LTD Granted P. [read post]
4 Sep 2012, 7:38 am by mstein03
” This is consistent with the rulings in the previous chemical compound cases after KSR, such as Eisai Co. v. [read post]
10 Feb 2012, 7:32 am by Mark Zamora
 Clostridium difficile is a bacterium that can cause colitis and other intestinal conditions.The FDA said patients who develop diarrhea after taking these drugs should be checked for CDAD.The drugs called proton pump inhibitors (PPIs) are widely used for treating ulcers, acid reflux and other conditions.Other PPIs sold by prescription include Takeda Pharmaceutical Co Ltd's Dexilant and Prevacid, AstraZeneca's Prilosec and Vimovo, Santarus Inc's Zegerid, and… [read post]
14 Jun 2011, 12:21 pm by John Elwood
  The Court GVR’ed with instructions to dismiss as moot in Eisai Co. v. [read post]
7 Jun 2011, 12:30 pm by Christa Culver
Title: Ritchie Special Credit Investments, Ltd. v. [read post]
20 May 2011, 3:06 pm
Eisai Co., Ltd., 620 F.3d 1341, 1346-48 (Fed. [read post]
15 Sep 2010, 2:40 am by Kelly
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]